Nitrosamine Impurities Testing in Duloxetine Drug Products: Ensuring Safety and Compliance
Introduction In recent years, the pharmaceutical industry has intensified its focus on Nitrosamine Impurities testing in Duloxetine, driven by stringent […]
Duloxetine Impurity NDSRI Testing: How to Quantify Nitroso Impurities A, B, C, E, and F by LC-MS
Introduction Because of recall of Duloxetine tablets due to nitrosamine impurityes, One of the most important aspects in pharmaceutical impurity
Top 5 APIs That Require Custom Nitrosamine Confirmatory Testing in 2025
In 2025, Custom Nitrosamine Confirmatory Testing has become an essential component of regulatory compliance for pharmaceutical manufacturers. The industry has
Top 5 APIs That Require Custom Nitrosamine Confirmatory Testing in 2025 Read More »
Nitrosamine Testing for API Drug Substance: Your Compliance Checklist for 2025
The global pharmaceutical industry faces increasing regulatory scrutiny over nitrosamine impurities in drug products. In Canada and internationally, regulatory agencies
Nitrosamine Testing for API Drug Substance: Your Compliance Checklist for 2025 Read More »